Download presentation
Presentation is loading. Please wait.
1
Sclerotherapy of telangiectasias using 0
Sclerotherapy of telangiectasias using 0.2% sodium tetradecyl sulfate before (left) and 8 weeks after treatment (right). Source: Lower Extremity Venous Disease, Venous and Lymphatic Diseases Citation: Dieter RS, Dieter RA, Jr., Dieter RA, III. Venous and Lymphatic Diseases; 2016 Available at: Accessed: November 05, 2017 Copyright © 2017 McGraw-Hill Education. All rights reserved
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.